Y-mAbs Therapeutics (NASDAQ:YMAB) Rating Lowered to Hold at Zacks Investment Research – TechNewsObserver
Y-mAbs Therapeutics (NASDAQ:YMAB) Rating Lowered to Hold at Zacks Investment Research TechNewsObserver
Y-mAbs Therapeutics (NASDAQ:YMAB) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday, …
Source: Investment New Feed